Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment: The TAILORx Trial.

Trial Profile

Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment: The TAILORx Trial.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 04 Nov 2013

At a glance

  • Drugs Anastrozole (Primary) ; Exemestane (Primary) ; Letrozole (Primary) ; Tamoxifen (Primary) ; Antineoplastics
  • Indications Adenocarcinoma; Breast cancer; Early breast cancer
  • Focus Therapeutic Use
  • Acronyms PACCT-1; TAILORx
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 21 Sep 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 21 Sep 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top